Vaccines are useful for prevention, but certain precautions are also necessary. Click here for symptoms.
Shingles, also known as shingles, is a disease caused by reactivation of the chickenpox virus.
And after the patient recovers from the virus, the virus remains dormant in the body but remains inactive. When reactivated, it causes rashes and blisters around the body, often very painful. .
In fact, this body pain is so intense that it can remain even after the rash has disappeared.
Shingles symptoms by clinic in May
Pain, burning, tingling.
touch sensitivity.
A red rash that appears a few days after the pain.
A fluid-filled blister that breaks and forms a scab.
itch.There are also people who:
heat.
headache.
light sensitivity.
Malaise.
Is it contagious?
Because it is derived from the chickenpox virus, many may believe that this cold sore is contagious as well, but this is not entirely true.
According to the U.S. Centers for Disease Control and Prevention, “Direct contact with the secretions from rash blisters can spread VZV to people who have never had chickenpox or who have never been vaccinated against chickenpox.”
Similarly, the organization adds that if a person becomes infected, they will develop chickenpox, but not this herpes, but it may develop later.
Still, it’s best to prevent infection with practical measures such as:
cover the rash
Do not touch or scratch the rash.
Until the rash has crusted over, avoid contact with:
– Pregnant women who have never had chickenpox or who have not been vaccinated against this disease.
– Premature or low birth weight babies.
– People with weakened immune systems.
Vaccines to prevent shingles
Treatment for shingles includes pain relievers, antiviral drugs, and can be prevented with vaccination. Vaccination against chickenpox in children or shingles in adults can usually minimize the risk of developing the disease.
vaccination Recommended for those over the age of 50 and over the age of 19, Especially when the immune system is weakened by other illnesses.
Recently, during the covid-19 pandemic, there has been a regrowth of herpes zoster worldwide. As a result, a new vaccine has been approved –Shinrix from the GSK Institute – reduces the risk of spreading disease.
This is a two-dose regimen, 2 to 6 months apart, for immunologically at-risk individuals aged 50 and older and 18 and older.
The vaccine is already approved in the US, European countries and Brazil.
Although not everyone who has chickenpox develops shingles, the Argentinean Dermatological Association (SAD) The symptoms of emotional stress and depression experienced during the pandemic have become much more frequent.
Source: Biobiochile